This week we speak with Scott Ford, CEO and Co-Founder of Westrock Coffee.
Westrock entered into a $1.1 billion combination agreement with Riverview Acquisition Corp. (Nasdaq: RVAC) in April of 2022, and has grown into the #1 wholesale provider of coffee and tea to US restaurants. Westrock is now looking to use its SPAC deal to make a big move into cold brew, made in the United States.
Scott explains how the company has worked to insulate itself from supply chain and commodity disruptions and why a SPAC deal was preferable to an IPO or more trips to the private equity watering hole.
Give it a listen
At the SPAC of Dawn Amid a restive market, SPACs have front-loaded their business this week with three of their four votes set for today and tomorrow. One of these is a completion vote, in which Bowen (NASDAQ:BOWN) will try and secure shareholder approval for its combination with Shenzhen Qianzhi BioTechnology just after having gained...
Terms Tracker for the Week Ending January 10, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This was the first full week in January and the first non-holiday week since December 23rd. All the same, 2025 has started with a bang...
Origin Investment Corp I has filed for a $60 million SPAC to hunt for an Asian target outside of China and marks ThinkEquity’s entry into the 2025 SPAC IPO market. ThinkEquity took all of 2024 off from directly underwriting SPACs as a left lead and has not brought one all the way to IPO since...
Rarely does a group of companies go through a complete industry-defining roller coaster in a matter of weeks based on the comments of two CEOs not of their direct subsector, but that is exactly the kind of winter that quantum computing companies are having. And, despite the recent valley that followed the spike, the three...
At the SPAC of Dawn The markets return from their short funeral break still in the red, but the 8:30 am ET dropping of employment and wage indicators could make this a harder or softer return to business. Drugs Made In America (NASDAQ:DMAAU) is expected to make its debut during this session as the year’s...